GlaxoSmithKline sets sights on mid-century carbon neutrality
Drug company GlaxoSmithKilne has committed to becoming carbon neutral by 2050. It has already cut emissions by 4% over the past three years, but questions remain over how it will achieve its goal.
Sorry you do not have access to this article. Please contact Customer Support at
or call 020 8267 8120